Iopofosine I 131 is a potential first-in-class, novel cancer targeting agent utilizing a phospholipid ether as a radioconjugate monotherapy. The FDA previously granted Orphan Drug Designation for ...
A Polish study comparing insulin pump technologies in children with type 1 diabetes found that advanced hybrid closed-loop ...
Significant proteinuria reduction maintained at one year, regardless of immunosuppressant use or baseline proteinuria levels Complete proteinuria remission (UPCR =0.5 g/g) achieved in one-third of pat ...
Detailed price information for Apellis Pharmaceuticals Inc (APLS-Q) from The Globe and Mail including charting and trades.
Tia, the leading provider of whole-person women’s healthcare, today announced the launch of its Hormone & Vitality Assessment ...
LYNCHBURG, Va. (WSET) — Women from all across Lynchburg participated in the “I am Woman” 5k Saturday morning, hosted by ...
Lung06 Phase 3 Trial of ENHERTU Initiated as First-Line Therapy in Patients with HER2 Overexpressing Metastatic NSCLC ...
Nonfactor therapies may reduce costs associated with bleeding-related hospitalizations and use of bypassing agents. One study ...
Discusses Immunology Portfolio Update and Advances in Autoimmune Therapies October 30, 2025 11:30 AM EDTCompany ...
WASHINGTON, Oct 6 (Reuters) - U.S. President Donald Trump on Monday congratulated Japan's hardline conservative Sanae Takaichi, who is on course to become the country's first female prime minister.